Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin.

[1]  D. Wheatley,et al.  Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. , 1990, The Annals of thoracic surgery.

[2]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[3]  M. Pfisterer,et al.  TRIAL OF LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE VERSUS ANTICOAGULANTS FOR PREVENTION OF AORTOCORONARY VEIN GRAFT OCCLUSION , 1989, The Lancet.

[4]  F. Sebening,et al.  Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients , 1989, The Thoracic and cardiovascular surgeon.

[5]  H. Reichenspurner,et al.  Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. , 1989, The Journal of thoracic and cardiovascular surgery.

[6]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[7]  M. Sunamori,et al.  Role of protease inhibition in myocardial preservation in prolonged hypothermic cardioplegia followed by reperfusion. Effect of aprotinin in an experimental model. , 1988, The Journal of thoracic and cardiovascular surgery.

[8]  Thomas E. Moritz,et al.  Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. , 1988, Circulation.

[9]  B. Weksler,et al.  Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis. , 1987, The Annals of thoracic surgery.

[10]  G. Magovern,et al.  Internal mammary artery grafting. Clinical results, patency rates, and long-term survival in 833 patients. , 1986, The Journal of thoracic and cardiovascular surgery.

[11]  F. Loop,et al.  Determinants of blood utilization during myocardial revascularization. , 1985, The Annals of thoracic surgery.

[12]  B. Weksler,et al.  Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. , 1985, Circulation.

[13]  E. Michelson,et al.  Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. , 1978, The Journal of thoracic and cardiovascular surgery.

[14]  T. Yeh,et al.  Blood loss and bank blood requirement in coronary bypass surgery. , 1978, The Annals of thoracic surgery.

[15]  C. Wildevuur,et al.  Preserved Hemostasis During the Combined Use of Aprotinin and Aspirin in CABG Operations , 1991 .

[16]  S. Ferraris,et al.  Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. , 1988, The Annals of thoracic surgery.